1 Product identity
Ingredient risk
1 ingredient to use with caution
Glucosamine & Chondroitin Sulfate
BrandGlucoflex→Non-Nutrient/Non-Botanical Other (e.g. tea bag) 8 ingredients 1 caution DSLD #71089Net contents: 120 Caplet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2017-02-24
2 Ingredients (8)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Film CoatCoating—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Chondroitin — Limited Evidence
⚠ May enhance anticoagulants
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID71089
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2017-02-24
6 More from Glucoflex
View Glucoflex Safety Scorecard → 3 products
Glucosamine & Chondroitin SulfateHyaluronic Acid7 Cite this page
Vancouver
Pkhakadze G. Glucosamine & Chondroitin Sulfate — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/dsld-71089/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG